Skip to main content

Table 2 Cumulative incidence of severe sepsis in cirrhotic patients admitted to intensive-care units between 2005 and 2010

From: Impact of chronic hepatitis C on mortality in cirrhotic patients admitted to intensive-care unit

  Control-group CHC-group p-value
Severe sepsis 1511 (36.6 %) 431 (37.9 %) 0.456
Acute organ dysfunction
 Respiratory 1329 (88 %) 365 (84.7 %) 0.963
 Cardiovascular 1018 (67.4 %) 283 (65.7 %) 0.920
 Renal 1036 (68.6 %) 288 (66.8 %) 0.919
 Hematological 469 (31 %) 124 (28.8 %) 0.697
 Metabolic 254 (16.8 %) 84 (19.5 %) 0.154
 Neurological 222 (14.7 %) 43 (10 %) 0.035
 Hepatic 556 (36.8 %) 146 (33.9 %) 0.606
Site of infection
 Respiratory 515 (34.1 %) 157 (36.4 %) 0.259
 Digestive 896 (59.3 %) 267 (61.9 %) 0.222
 Genitourinary 171 (11.3 %) 46 (10.7 %) 0.946
 Central nervous system 16 (1.1 %) 9 (2.1 %) 0.132
 Skin, soft tissue, or bone 87 (5.8 %) 33 (7.7 %) 0.141
 Circulatory 39 (2.6 %) 8 (1.9 %) 0.555
  1. Values are expressed as absolute numbers (percentages). P-values were calculated using the chi-squared test. The sum of sites of infection is greater than the number of patients with severe sepsis because a patient may have more than one site of infection
  2. Abbreviation: CHC chronic hepatitis C virus